Secondary Logo

Journal Logo

Chikugunya and zika virus dissemination in the Americas: different arboviruses reflecting the same spreading routes and poor vector-control policies

Fernández-Salas, Ildefonso; Díaz-González, Esteban E.; López-Gatell, Hugo; Alpuche-Aranda, Celia

Current Opinion in Infectious Diseases: October 2016 - Volume 29 - Issue 5 - p 467–475
doi: 10.1097/QCO.0000000000000304
TROPICAL AND TRAVEL-ASSOCIATED DISEASES: Edited by Joseph M. Vinetz and Yukari C. Manabe

Purpose of review This review gathers the most recent investigations about chikungunya and zika viruses in America and would help in creating new research approaches.

Recent findings Clinical descriptions of chikungunya fever have been performed in the American outbreak observing that fever, polyarthalgia, myalgia and rash are the most common symptoms in the acute phase, while chronic arthralgia has persisted in 37–90% of small cohorts. The Asian origin of American strains of chikungunya virus (CHIKV) and zika virus (ZIKV) evidences a dissemination route in common and both are being transmitted by Aedes aegypti. Regarding zika fever, the association of congenital malformations with previous ZIKV exposure of pregnant women and potential sexual transmission of ZIKV are the most important discoveries in the New World.

Summary Massive outbreaks of chikungunya fever in 2014 and then followed by zika fever epidemics of lower magnitude in the next year throughout the American continent have their origins in Asia but may have used Pacific Islands as a path of dissemination. Reports of chronic arthralgia have been little described in the continent and more research is needed to measure the economic and health impact in patients who contracted CHIKV before. On the contrary, zika is menacing newborns’ health because of its link with congenital microcephaly and sexual health by prolonged presence of viral particles in semen and urine.

aCentro Regional de Investigación en Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Chiapas

bCentro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León

cFacultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León

dCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico

*Ildefonso Fernández-Salas and Esteban E. Díaz-González contributed equally to this study.

Correspondence to Ildefonso Fernández-Salas, Centro Regional de Investigación en Salud Publica, Instituto Nacional de Salud Pública, 19 Poniente s/n entre 4 Norte y 6 Norte, Centro, Tapachula, Chiapas 30700, México. Tel: +52 962 626 2219 ext. 120; e-mail:

Back to Top | Article Outline


Although zika virus (ZIKV) is strongly calling attention since the beginning of 2016 due to the World Health Organization international alert, we cannot forget that currently the same Latin-American countries are experiencing more outbreaks and suffering with prolonged joint sequels of past chikungunya fever (CHIKF) epidemics [1▪]. The overlapping circulation of three arboviruses, dengue virus (DENV) included, is an historical opportunity for the academic field of infectious diseases to analyse and to learn the dynamics of public health epidemiology under this dramatic multipathogen scenario [2▪].

From their African original foci and after moving to Asia during several years, both viruses have flourished in naive Latin-American territories impacting with serious incidence rates mostly explained by finding abundant Aedes aegypti mosquito populations in urban and rural settings. Primary health attention centres now have to face patients showing confusing disease symptoms caused by these three arboviruses, that is haemorrhagic manifestations, painful articular swelling with lasting and debilitating damage and potential microcephaly of newborns, along with neurological symptoms such as Guillian-Barre. The hope of dengue vaccine for mass distribution has been diluted because governments are doubtful of its protecting effectiveness taking into account cocirculation of two viral families with differential immune response, that is Flaviviridae and Togaviridae.

The Dengue route, a golden triangle of the Caribbean islands, South and Central America (including Mexico), is a known road seeded with continuous epidemics and built after its reemergence in Latin America during the late 1970s [3]; it has remained untouchable since then and has been served now as the chikungunya virus (CHIKV) and ZIKV corridor. It is a geographical pattern matching smoothly with migrant and trade paths; however, these regions also hold perfect Ae. aegypti environments wherein poverty, tropical rainy season, including high moisture and temperature interact to rise abundant mosquito vector populations [4]. A serious concern is the fast speed that these two emergent arboviruses have disseminated through Latin America in a period of almost less than 2 years. Lack of herd immunity in Latin America along with enormous poorly controlled Ae. aegypti living domestically may have undoubtedly triggered important outbreak of CHIKV and ZIKV, but including a rise of Guillain-Barre syndrome cases and congenital malformations associated with the latter.

Box 1

Box 1

Back to Top | Article Outline


CHIKF emergence was announced for the first time in the American Continent with one autochthonous case in the island of Saint Martin in December 2013 [5▪]. However, an ancient introduction of CHIKV in the Caribbean has been proposed in base of its characteristic symptomology according to medical records of the nineteenth century. An outbreak with clinical diagnosis of CHIKF (formerly dengue) was reported in 1827–1828 in the islands of St. Thomas, St. Croix, St. Bartholomew's and Antigua. Then, it advanced towards the US in the cities of New Orleans, Charleston and Savannah at the end of 1828 [6]. After almost two centuries of absence, this alfavirus appeared, probably once again, causing thousands of cases throughout the continent.

Back to Top | Article Outline

Outbreaks in the Caribbean

The first spillover pattern in the Caribbean that CHIKV followed after Saint Martin island introduction occurred probably in Anguilla, St. Bartholomew, Martinique, British Virgin Islands and Guadeloupe, and a few months later, the rest of the Caribbean Islands was affected by CHIKF [7]. After this spreading including all Latin and Non-Latin Caribbean islands, they gathered up to 837 530 cases with an incidence rate of 1898.5 per 100 000 habitants during 2014. The most affected countries were Dominic Republic, Martinique, Guadeloupe, Haiti and Puerto Rico (Fig. 1). In the next year, these numbers considerably decreased to 18 265 cases with an incidence rate of 41.4 per 100 000 habitants being 45.8-fold lower than the previous year [8]. The most likely explanation of the first explosive magnitude of cases in the beginning of the outbreak and then an abrupt reduction in the next year may be due to the reduction of naive population to CHIKV infection after the first wave of cases. A big concern arose in the European community for receiving imported cases from Caribbean Islands because they are a common destination of European tourists [9]. Although the Caribbean outbreak was in its hottest stage in 2014, France and Spain received a considerable amount of imported cases from mainly French Caribbean and Haiti and Dominican Republic, respectively [10,11].



To date, Asian lineage of CHIKV is the only that has been circulating in the Caribbean since its introduction. Viral sequences of this lineage have been obtained from patients who resided in the British Virgin Islands and Trinidad being both closely related [12,13▪]. A theory that may explain the origin of Asian strain in the Americas is that CHIKV was introduced by human movement of tourism travellers and/or maritime trade from Asia. Months previous to the 2014 outbreak, 27.5% of tourism reported in the Caribbean came from China and Philippines [14] and ports in the Caribbean have served as intersections of East–West maritime trade routes linking Asia, America, Europe and the Middle East [15].

Back to Top | Article Outline

Spreading to mainland South and Central America

Although CHIKV had been attacking the Caribbean during the first 6 months since its introduction, the first eight autochthonous cases in the mainland America, specifically El Salvador, were officially reported in June 2014. One month later, Venezuela announced an outbreak of CHIKV with 30 autochthonous cases, and by September, CHIKV reached Colombia and Brazil reporting in both countries 42 and two autochthonous cases, respectively. A further dissemination of CHIKV continued in the rest of Central and South America countries during 2014. As the opposite occurred in Caribbean, the numbers of accumulated cases in Central and South America during 2014 were 172 736 and 133 773, respectively, being lower than 2015 numbers with 262 264 and 438 863 cases, respectively [8]. Brazil, Colombia and Venezuela accumulated most of the cases reported in South America (Fig. 1).

Transmission of CHIKV by Asian lineage has also been reported in Panama, Nicaragua, Colombia and Brazil [16,17,18▪▪,19▪▪], being all closely related to British Virgin Island strain from Caribbean; however, up this moment, Brazil is the unique country across the continent that ECSA lineage has been circulating. This lineage was reported for the first time in the Feira de Santana State in June 2014, and according to epidemiological and phylogenetic data, it is believed that Brazilian ECSA lineage had an origin from Angola [19▪▪], a former Portuguese colony that is an important trade allied of Brazil and where thousands of Brazilians work for the oil and mining industry [20,21].

Back to Top | Article Outline

North America: migration, spillover in Southern Mexico, local transmission in Florida and potential risks for the rest of us

By September 2014, one month after the beginning of the El Salvador outbreak, CHIKV appeared in Guatemala Republic reporting just eight cases, one from Escuintla city that is located approximately 200 km from the Mexico–Guatemala border. CHIKV took only 1 month to reach a border community in Chiapas, Southern Mexico, causing an outbreak of 94 patients [22], but this was confirmed months later by the official announcement of one CHIKF case in November by Mexican Ministry of Health [23]. Illegal migration from Central America and commerce may have led the movement of infected patients to Chiapas through the Mexico–Guatemala border. During 2015, the outbreak was moving northward along Pacific and Gulf of Mexico Coast and towards Yucatan Peninsula causing hundreds of cases, but stagnated in Northern Mexico with few cases near the US–Mexico border [24]. An unusual prolonged heatwave in midsummer and a short rainy season afterwards may explain the low number of cases in this region because of the poor environmental conditions for Ae. aegypti breeding [25].

With regard to the US scenario, this country was the only one that had an appropriate surveillance system to collect CHIKV cases before 2013. The US reported 164 imported CHIKV cases between 1995 and 2013 mainly from travellers who visited Asia and Africa [26,27]. After CHIKV emergence in America, imported cases arose up to 400, which probably most of 236 reported during June 2014 had a history of travel to Caribbean [28]. Finally, Florida through CDC reported officially two autochthonous cases in July 2014, but similarly as Mexico, 1 month before, 11 autochthonous cases were collected but reported until December by Florida Department of Health [29▪]. The final figure of locally transmitted cases of CHIKF during 2014 was 12 cases, and since then, no autochthonous cases have been notified. The absence of local transmission of CHIKV in the US may be explained due to effective labour of vector control services performed by mosquito control districts throughout Southern US [30,31]. In addition, a strong heatwave in midsummer and a short period of rains afterwards in Northern Mexico during 2015 could have hold back the CHIKV outbreaks outside the US.

Back to Top | Article Outline

Clinical and entomological investigations during American outbreak

Clinical and epidemiological information generated in ongoing CHIKV epidemics in America has been limited to specific outbreaks, but clinical data have adjusted to previously report in clinical guides from PAHO and La Reunion outbreak investigations. Overall attack rate is unknown in the whole continent, but research in a children cohort in Nicaragua gave an estimate of 2.9%. However, it may be underestimated, as this age group usually presents symptoms of an undifferentiated fever [16].

Trinidad and Tobago, Colombia and Mexico have published the first clinical findings of their outbreaks in the continent during the 2014–2015 outbreaks [13▪,17,32]. All reported that the main symptomatology was fever (100%), headache (64–94%), sever polyartharlgia (83–88%), rash (33–66%) and myalgia (28–94%). Biochemical parameters have been barely measured during these outbreaks, being coagulation tests in normal ranges but leukopenia was observed in the Mexican study during the first 2 days of symptomatology onset. The clinic of CHIKF and dengue has been compared and was clearly observed that haemorrhagic symptoms and low platelet levels were more frequent in dengue than in CHIKF patients, and inversely, severe polyarthralgia and leukopenia were more common in CHIKF patients [32].

In regard of persistent arthralgia that has been observed in chronic phase of CHIKF, little information has been described within 2 years since its introduction in America. Preliminarily in Colombia, a follow-up of two cohorts of 39 and 131 CHIKV-confirmed patients from Sincelejo and Tolima, respectively, has reported the postchikungunya chronic arthralgia (pCHIK-CRA) in 89.7 and 44.3% and with median time of duration of 37 and 24 weeks, respectively [33▪,34▪]. Another brief report of pCHIK-CPA in imported cases from the US has found that 37% of travellers who had contracted CHIKV in the Caribbean had persistent arthralgia and myalgia [35]. These results have their sample size limitations and are not conclusive for the rest of American outbreaks, but lead to further investigations about the health and economic impact of prolonged arthralgia in the Continent using quantitative methodologies such as applying DAS-28 and WHODAS 2.0 to assess the articular damage and the health and disability, respectively.

Previous CHIKV emergence in America and vector populations from this continent were evaluated to prove their ability to transmit CHIKV under laboratory conditions. Ae. aegypti was competent for Asian and ECSA genotypes; however, the transmission efficacy of the emerging Indic Ocean Lineage (strain CHIKV_0621), which is derived from ECSA genotype, was higher in American populations of Ae. albopictus[36,37▪▪]. The most important vector during the American epidemic is probably Ae. aegypti because its distribution is extensive and wider than Ae. albopictus in tropical and subtropical regions from America [38]; it has been incriminated during outbreaks in Chiapas and Yucatan States [39▪,40▪] and has been found infected in domestic populations from Guerrero State, Mexico [41]; the transmission of Asian genotype is constrained mainly to Ae. aegypti[42]; and at the time of writing this manuscript, there is no evidence of the appearance of adaptive mutations to become Ae. albopicuts as an effective vector [43▪▪]. Countries with temperate regions where tiger mosquito breed, such as US and European countries, cannot discard a future role of Ae. albopictus as a CHIKV vector. The proven ability of CHIKV to evolve and adapt to a new vector should maintain surveillance activities focused on this mosquito.

Back to Top | Article Outline


While chikungunya outbreaks were affecting thousands of persons throughout America, another arbovirus unexpectedly emerged in the continent in spite of all efforts for vector control activities: zika virus. In the beginning of 2015, local transmission of ZIKV occurred in the Northeast of Brazil causing eight cases [18▪▪]. From this moment, the virus spread to South America (except Chile, Argentina, Uruguay and Peru), Caribbean, Central America and finally Mexico during 2015. Currently, the US and Canada have been free of ZIKV transmission, but the risk is latent. To date, a total of 227 929 suspected and 7698 confirmed cases of zika fever (ZIKF) have been reported in the whole continent. The countries that gather the most amount of cases are Brazil (30.4%), Colombia (29.1%), Venezuela (13.4%), Honduras (7.7%), Martinique (7.6%) and El Salvador (4.7%) (Fig. 1). Genetic evidence from some American strains exhibits that Asian genotype of ZIKV is currently circulating in America and the strains were most closely related to a 2013 isolate from French Polynesia into Asian clade. In the base of molecular evidence, the introduction of ZIKV could have taken place from infected patients who travelled since Pacific Islands had ongoing ZIKV outbreaks until Brazil [44▪▪].

In Mexico, only 239 cases have been reported since its introduction in November 2015 [45]. The majority of cases (235) were observed in Southern States of Mexico: Chiapas, Guerrero, Tabasco, Veracruz, Yucatan, Oaxaca, Michoacan, Jalisco and Nayarit. The Northern State of Nuevo Leon, which is part of the Mexico–US border, reported just four cases in 2015, but during 2016, none of the Border States with the US have had a ZIKV case. In the same way observed in the behaviour of CHIKV outbreak, ZIKV epidemic remained in Southern States of Mexico probably for the same reason of long heatwave during midsummer 2015 in Northern Mexico.

Back to Top | Article Outline

Vectorial and sexual transmission

ZIKV, like another member of genus Flavivirus, is a vector-borne disease transmitted mainly by Aedes mosquitoes. Sylvatic species of these genera have been involved in enzootic transmission and it is believed that urban vectors Ae. aegypti and Ae. albopictus have participated in the urban cycle of transmission in Africa and Asia before 2008. In Pacific epidemics of 2007–2013, Ae. helsiinii and Ae. aegypti were probable vectors of ZIKV because of their high presence in household environments during outbreaks [46▪]. The first incrimination of Ae. aegypti under natural transmission conditions was demonstrated at the end of 2015 in Southern Mexico. During the ZIKV outbreak in Tapachula, Chiapas, this vector was found infected in houses with ZIKV-confirmed patients. Partial NS5 sequences derived from sera of these patients had no more than one nt difference from the mosquito strains, confirming a transmission link. Suspicious role of Culex quinquefasciatus as a ZIKV vector has recently arisen but in this study was not found infected [47▪▪]. Entomological situation in America has offered to ZIKV the perfect scenario for rapid dissemination throughout the continent as similarly observed for CHIKV [24].

Apart from the vector–human–vector transmission cycle, a suspicion of another potential transmission mechanism has arisen in a report of US native who came back from Senegal sick of ZIKF and likely transmitted the virus to his wife through sexual intercourse [48]. In addition, viral particles have been detected in semen and urine in patients who had been infected by ZIKV days or weeks before [49▪▪,50▪▪,51▪]. It is unknown how this transmission mechanism is currently influencing ZIKV outbreaks in America.

Back to Top | Article Outline

Associated microcephaly: case reports and prelaminar case–control study in Brazil

Unexpectedly, an alarming rise of newborns with microcepahly begun to be observed during 2015. Early 2016, the incidence rate of microcephaly incremented 20-fold reaching 99.7 cases per 100 000 newborns of whom 76 have died [52▪]. At this moment, 5640 microcephaly cases have been reported of whom only 583 were born from a mother with a previous infection of ZIKV during her pregnancy [53]. Report cases have been described seeking ZIKV infection in pregnant women, miscarried foetus and deceased newborns with microcephaly. One study detected and sequenced the virus that was found in amniotic fluid from two pregnant Brazilian females who carried foetus with microcephaly [52▪]. Another report describes a Slovenian woman, who had sickened of ZIKF in the 13th week of gestation in Brazil, with interrupted pregnancy at the eighth month and the miscarried foetus with microcephaly showed evidence of infection in brain tissue [54▪▪]. Similar report of two foetal losses and two congenital ZIKV-infected newborns from Brazil confirmed the infection in brain tissue and also placental tissue had evidence of ZIKV infection from early miscarriages [55]. A preliminary case–control study was carried out in Brazil in a prospective cohort of 88 women of whom 72 (82%) were ZIKV-positive, but foetal ultrasonography was performed only in 42 women (58%). From these patients, foetal abnormalities were observed in 12 (29%) and none in ZIKV-negative pregnant woman. The abnormalities included foetal death, foetal growth restriction and mainly central nervous system (CNS) injuries [56▪▪]. Despite these evidences suggesting a likely association of ZIKV infection during pregnancy and microcephaly in foetus, full case–control studies are necessary to establish finally the causality of congenital malformations in the CNS by vertical transmission of ZIKV [57].

Back to Top | Article Outline


A similar transcontinental route has been traced by ZIKV and CHIKV according to recent phylogenetic studies. Although both viruses found in America belong to CHIKV and ZIKV Asian genotypes, they are more related with Pacific Islands of Yap strain (2013) and French Polynesia strain (2013), respectively [44▪▪,58▪▪]. Thus, both viruses crossed from Asia to Western Hemisphere using the Pacific Islands as a bridge (Fig. 2). Massive sport events such as World Cup Soccer and canoe tournaments have been proposed as the cause of ZIKV introduction to Brazil, but recent molecular findings suggest that large-scale patterns of human mobility explain better the introduction of ZIKV in America [59]. Therefore, human movement among continents serves as the appropriate pathway for CHIKV and ZIKV dissemination.



Back to Top | Article Outline


During the annual outbreaks of DENV in the last two decades, CHIKV and ZIKV received little attention in that time. The magnitude of pandemics of these last arboviruses was not expected and the consequences have been little encouraging: long-term disability by prolonged arthralgia, congenital malformations (microcephaly) and neurological disorders such as Guillain-Barré. Which is the scenario of vector-borne diseases in the following years? The horizon is shady, but there are other arboviruses waiting in the line. The Rockefeller Foundation granted surveillance programs of Yellow fever virus (YFV) and other arboviruses until 1970 and this initiative achieved important goals discovering new arboviruses, their ecology and human activity in Africa [60▪▪]. Potential emerging flavivirus, alfavirus and orthobunyavirus that probably cocirculated with ZIKV, CHIKV and YFV in the past would be the strongest candidates to become the most important vector-borne diseases in the future [61–72]. Within Flavivirus, Uganda S virus (UGSV), Wesselsbron virus (WESSV) and Kedougou virus (KEDV) were most commonly found in seroprevalence studies and they group into clades of Aedes-associated flavivirus [73]. Similar studies of Alfavivurs, Semliki Forest virus (SFV) and epidemic polyarthritis Ross-River virus and Barmah Forest viruses are potential arthalgic-virus transmitted by Aedes. Finally, the most common seroprevalent virus belonging to Orthobunyavirus genus is Bunyamwera virus (BUNV) and potentially transmitted by Aedes mosquitoes too [74]. Despite these studies being not conclusive because of the low specificity of serologic techniques used, ZIKV was also reported along these arboviruses.

In addition, there is an American arbovirus that has sporadically turned up from its enzootic cycles in Trinidad and Amazonas rainforests: Mayaro virus (MAYV). Another arthralgic virus related to CHIKV and SFV has recently emerged in Panama in 2016 and has the same urban potential to be dispersed [75]. A last question is in the air: will any of these known arboviruses have the same potential to be spread in urban transmission cycles worldwide such as DENV, CHIKV and ZIKV? What about unknown arboviruses? Only time will tell us.

Back to Top | Article Outline


Chikungunya and zika viruses, both transmitted by Aedes aegypti, have become an important public health issue favoured by lack of vaccines and efficient vector control methods. A new scenario of three different arboviruses cocirculating in the same regions has alarmed the academic community and new strategies should be proposed for the control of this vector. No matter how many vaccines could be developed, the risk of introduction of new arboviruses is always latent.

Back to Top | Article Outline


We would like to thank Rosa M. Sanchez-Casas for her assistance with the manuscript.

Back to Top | Article Outline

Financial support and sponsorship


Back to Top | Article Outline

Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline


Papers of particular interest, published within the annual period of review, have been highlighted as:

  • ▪ of special interest
  • ▪▪ of outstanding interest
Back to Top | Article Outline


1▪. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016; 374:1552–1563.

This study provides a complete recopilation of ZIKV information.

2▪. Cardoso CW, Paploski IAD, Kikuti M, et al. Outbreak of exanthematous illness associated with Zika, chikungunya, and dengue viruses, Salvador, Brazil. Emerg Infect Dis 2015; 21:2274–2276.

The first report of concomitant transmission of DENV, CHIKV and ZIKV in America.

3. Brathwaite Dick O, San Martin JL, Montoya RH, et al. The history of dengue outbreaks in the Americas. Am J Trop Med Hyg 2012; 87:584–593.
4. Kraemer MUG, Sinka ME, Duda KA, et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife 2015; 4:e08347.
5▪. Cassadou S, Boucau S, Petit-Sinturel M, Huc P. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill 2014; 19:pii: 20752.

The first report of CHIKV in America.

6. Halstead SB. Reappearance of chikungunya, formerly called dengue, in the Americas. Emerg Infect Dis 2015; 21:557–561.
7. Cauchemez S, Ledrans M, Poletto C, et al. Local and regional spread of chikungunya fever in the Americas. Euro Surveill 2014; 19:20854.
8. Pan American Health Organization. Chikungunya: statistic data [Internet]. World Health Organization. 2016. [Accessed 13 April 2016]
9. Noël H, Rizzo C. Spread of chikungunya from the Caribbean to mainland Central and South America: a greater risk of spillover in Europe? Euro Surveill 2014; 19:20855.
10. Requena-Mendez A, Garcia C, Aldasoro E, et al. Cases of chikungunya virus infection in travellers returning to Spain from Haiti or Dominican Republic, April-June 2014. Euro Surveill 2014; 19:20853.
11. Paty MC, Six C, Charlet F, et al. Large number of imported chikungunya cases in mainland France, 2014: a challenge for surveillance and response. Euro Surveill 2014; 19:20856.
12. Lanciotti RS, Valadere AM. Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis 2014; 20:1400–1402.
13▪. Sahadeo N, Mohammed H, Allicock OM, et al. Molecular characterisation of chikungunya virus infections in trinidad and comparison of clinical and laboratory features with dengue and other acute febrile cases. PLoS Negl Trop Dis 2015; 9:e0004199.

First attempts of clinical description in the Caribbean and comparison with DENV symptomatology.

14. Khan K, Bogoch I, Brownstein JS, et al. Assessing the origin of and potential for international spread of chikungunya virus from the Caribbean. PLoS Curr 2014; 6:pii: ecurrents.outbreaks.2134a0a7bf37fd8d388181539fea2da5.
15. Pinnock FH, Ajagunna IA. The Caribbean Maritime Transportation Sector: achieving sustainability through efficiency. Ontario: Centre for International Governance Innovation; 2012.
16. Balmaseda A, Gordon A, Gresh L, et al. Clinical attack rate of chikungunya in a cohort of Nicaraguan children. Am J Trop Med Hyg 2016; 94:397–399.
17. Mattar S, Miranda J, Pinzon H, et al. Outbreak of Chikungunya virus in the north Caribbean area of Colombia: clinical presentation and phylogenetic analysis. J Infect Dev Ctries 2015; 9:1126–1132.
18▪▪. Zanluca C, de Melo VCA, Mosimann ALP, et al. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 2015; 110:569–572.

This is the first report of eight autochthonous ZIKF cases in Brazil.

19▪▪. Nunes MRT, Faria NR, deVasconcelos JM, et al. Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med 2015; 13:102.

This study describes the emergence pathway of this disease and reports two genotypes: Asian and ECSA.

20. Morosini FC, Sanchez Badin MR. The Brazilian approach to south-south trade and investment: the case of Angola [Internet]. Social Science Research Network 2016; [Accessed April 13 2016].
21. Sistema IBGE de Recuperacao Automatica. Emigrantes internacionais, por sexo, segundo os continentes e países estrangeiros de destino [Internet]. Instituto Brasileiro de Geografia e Estatística. [Accessed 13 April 2016]
22. Kautz TF, Díaz-González EE, Erasmus JH, et al. Chikungunya virus as cause of febrile illness outbreak, Chiapas, Mexico, 2014. Emerg Infect Dis 2015; 21:2070–2073.
23. Centro Nacional de Programas Preventivos y Control de Enfermedades. Declaratoria de Emergencia Epidemiológica EE-2–2014 para el estado de Chiapas ante el primer caso de transmisión autóctona de enfermedad por virus de Chikungunya. [Internet]. 2014. [Accessed 17 April 2016]
24. Fernández-Salas I, Danis-Lozano R, Casas-Martínez M, et al. Historical inability to control Aedes aegypti as a main contributor of fast dispersal of chikungunya outbreaks in Latin America. Antiviral Res 2015; 124:30–42.
25. Servicio Metereológico Nacional. Reporte anual 2015 [Internet]. Comisión Nacional del Agua. 2016. [Accessed 14 April 2016]
26. Gibney KB, Fischer M, Prince HE, et al. Chikungunya fever in the United States: a fifteen year review of cases. Clin Infect Dis 2011; 52:e121–e126.
27. Lindsey NP, Prince HE, Kosoy O, et al. Chikungunya virus infections among travelers–United States, 2010–2013. Am J Trop Med Hyg 2015; 92:82–87.
28. Carter D. Chikungunya virus spreads to the United States via Caribbean travel. Am J Nurs 2014; 114:18.
29▪. Kendrick K, Stanek DR, Blackmore CGM. Transmission of chikungunya virus in the continental United States – Florida, 2014. Morb Mortal Wkly Rep 2014; 63:1137.

This study reports the local transmission of CHIKV in the USA for the first time.

30. Porse CC, Kramer V, Yoshimizu MH, et al. Public health response to Aedes aegypti and Ae. albopictus mosquitoes invading California, USA. Emerg Infect Dis J 2015; 21:1827.
31. Monaghan AJ, Morin CW, Steinhoff DF, et al. On the seasonal occurrence and abundance of the Zika virus vector mosquito Aedes Aegypti in the contiguous United States. PLoS Curr 2016; pii:ecurrents.outbreaks.50dfc7f46798675fc63e7d7da563da76.
32. N.-Espinosa J, G.-Ibarra J, Cruz.-Tinoco CES, et al. Clinical behavior of dengue and chikungunya infections in the Instituto Mexicano del Seguro Social. Open J Med Microbiol 2016; 6:23–31.
33▪. Rodriguez-Morales AJ, Villamil-Gomez W, Merlano-Espinosa M, Simone-Kleber L. Postchikungunya chronic arthralgia: a first retrospective follow-up study of 39 cases in Colombia. Clin Rheumatol 2016; 35:831–832.

First reports of chronic arthalgia in America.

34▪. Rodríguez-Morales AJ, Calvache-Benavides CE, Giraldo-Gómez J, et al. Postchikungunya chronic arthralgia: results from a retrospective follow-up study of 131 cases in Tolima, Colombia. Travel Med Infect Dis 2016; 14:58–59.

A deeper description of chronic arthalgia in a bigger cohort, showing a high prevalence of this disease among previoulsy infected patients.

35. Zeana C, Kelly P, Heredia W, et al. Postchikungunya rheumatic disorders in travelers after return from the Caribbean. Travel Med Infect Dis 2016; 14:21–25.
36. Vega-Rúa A, Zouache K, Girod R, et al. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus. J Virol 2014; 88:6294–6306.
37▪▪. Vega-Rúa A, Lourenço-de-Oliveira R, Mousson L, et al. Chikungunya virus transmission potential by local Aedes mosquitoes in the Americas and Europe. PLoS Negl Trop Dis 2015; 9:e0003780.

This study assesed that the vector competence of American Aedes populations to CHIKV and Asian lineage is better transmited by Ae. aegypti while ECSA genotype (including IOL lineage) by Ae. albopictus.

38. Campbell LP, Luther C, Moo-Llanes D, et al. Climate change influences on global distributions of dengue and chikungunya virus vectors. Philos Trans R Soc Lond B Biol Sci 2015; 370:20140135.
39▪. Díaz-González E, Kautz T, Dorantes-Delgado A, et al. First report of Aedes aegypti transmission of chikungunya virus in the Americas. Am J Trop Med Hyg 2015; 93:1325–1329.

First attempt to incriminate Ae. aegypti as a vector of CHIKV in Mexico.

40▪. Nohemi Cigarroa-Toledo, et al.. Chikungunya Virus in Febrile Humans and Aedes aegypti Mosquitoes, Yucatan, Mexico. Emerg Infect Dis 2016; 22: In press. doi: 10.3201/eid2210.152087

During an outbreak in Yucatan State, CHIKV was isolated from human and mosquitoes and one co-infected patient with DENV-1 was found.

41. Dzul-Manzanilla F, Martínez NE, Cruz-Nolasco M, et al. Evidence of vertical transmission and co-circulation of chikungunya and dengue viruses in field populations of Aedes aegypti (L.) from Guerrero, Mexico. Trans R Soc Trop Med Hyg 2016; 110:141–144.
42. Tsetsarkin KA, Chen R, Leal G, et al. Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A 2011; 108:7872–7877.
43▪▪. Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med Mass 2015; 372:1231–1239.

A complete recopilation of latest research about CHIKV.

44▪▪. Lanciotti RS, Lambert AJ, Holodniy M, et al. Phylogeny of Zika virus in western hemisphere, 2015. Emerg Infect Dis J 2016; 22:933–935.

This study describes the pathway of ZIKV since Africa and then how it was disseminated to Asia, Pacific and finally to America, keeping this order.

45. Comisión Nacional para la Vigilancia Epidemiológica. Infección por virus Zika, síndrome neurológico y anomalías congénitas [Internet]. Sistema Nacional para la Vigilancia Epidemiológica, Secretaría de Salud. 2015. [Accessed 18 April 2016]
46▪. Ayres CFJ. Identification of Zika virus vectors and implications for control. Lancet Infect Dis 2016; 16:278–279.

Until this moment, none vector has been incriminated in natural conditions during ZIKV outbreaks.

47▪▪. Mathilde Guerbois, et al.. Outbreak of Zika virus infection, Chiapas State, Mexico, 2015, and first confirmed transmission by Aedes aegypti mosquitoes in the Americas. J Infect Dis 2016; In press. doi: 10.1093/infdis/jiw302.

This report provides the evidence that Ae. aegypti is the main vector of ZIKV in North America.

48. Foy BD, Kobylinski KC, Foy JLC, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis J 2011; 17:880.
49▪▪. Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015; 21:359–361.

This study proposes a new mechanism of ZIKV transmission through sexual intercourse.

50▪▪. D’Ortenzio E, Matheron S, de Lamballerie X, et al. Evidence of sexual transmission of zika virus. N Engl J Med 2016; 374:2195–2198.

More evidence supporting the sexual transmission of ZIKV.

51▪. Atkinson B, Hearn P, Afrough B, et al. Detection of Zika virus in semen. Emerg Infect Dis J 2016; 22:940.

This study reports the presence of virus in semen from patients who have infected days before.

52▪. Calvet G, Aguiar RS, Melo ASO, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016; 16:653–660.

Evidence of ZIKV infection in amniotic fluid that suggest a linkage of this disease with microcephaly in foetuses.

53. Pan American Health Organization. Cumulative Zika suspected and confirmed cases reported by countries and territories in the Americas, 2015–2016 [Internet]. [Accessed 20 April 2016]
54▪▪. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med 2016; 374:951–958.

This study reports evidence of ZIKV infection in brain tissue from a miscarried foetus with microcephaly.

55. Martines RB, Bhatnagar J, Keating MK, et al. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses – Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:159–160.
56▪▪. Brasil P, Pereira JP, Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro: preliminary report. N Engl J Med 2016; [Epub ahead of print].

A preliminary case–contol study to establish an association of ZIKV infection with congenital malformations.

57. Musso D, Baud D. Zika virus: time to move from case reports to case control. Lancet Infect Dis 2016; 16:620–621.
58▪▪. Lanciotti RS, Lambert AJ. Phylogenetic analysis of chikungunya virus strains circulating in the western hemisphere. Am J Trop Med Hyg 2016; 94:800–803.

This study describes the pathway of CHIKV since Africa and then how was disseminated to Asia, Pacific and finally to America, keeping this order.

59. Faria NR, Azevedo Rdo S, Kraemer MU, et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 2016; 352:345–349.
60▪▪. Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev 2016; 29:487–524.

The most complete revision of ZIKV.

61. Smithburn KC. Studies on certain viruses isolated in the tropics of Africa and South America; immunological reactions as determined by cross-neutralization tests. J Immunol 1952; 68:441–460.
62. Dick GW. Epidemiological notes on some viruses isolated in Uganda (Yellow fever, Rift Valley fever, Bwamba fever, West Nile, Mengo, Semliki forest, Bunyamwera, Ntaya, Uganda S and Zika viruses). Trans R Soc Trop Med Hyg 1953; 47:13–48.
63. Smithburn KC, Kerr JA, Gatne PB. Neutralizing antibodies against certain viruses in the sera of residents of India. J Immunol 1954; 72:248–257.
64. Pond WL. Arthropod-borne virus antibodies in sera from residents of South-East Asia. Trans R Soc Trop Med Hyg 1963; 57:364–371.
65. Moore DL, Causey OR, Carey DE, et al. Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 1975; 69:49–64.
66. Robin Y, Mouchet J. Serological and entomological study on yellow fever in Sierra Leone. Bull Soc Pathol Exot Filiales 1975; 68:249–258.
67. Fagbami A. Epidemiological investigations on arbovirus infections at Igbo-Ora, Nigeria. Trop Geogr Med 1977; 29:187–191.
68. Jan C, Languillat G, Renaudet J, Robin Y. A serological survey of arboviruses in Gabon. Bull Soc Pathol Exot Filiales 1978; 71:140–146.
69. Adekolu-John EO, Fagbami AH. Arthropod-borne virus antibodies in sera of residents of Kainji Lake Basin, Nigeria 1980. Trans R Soc Trop Med Hyg 1983; 77:149–151.
70. Darwish MA, Hoogstraal H, Roberts TJ, et al. A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan. Trans R Soc Trop Med Hyg 1983; 77:442–445.
71. Olson JG, Ksiazek TG, Gubler DJ, et al. A survey for arboviral antibodies in sera of humans and animals in Lombok, Republic of Indonesia. Ann Trop Med Parasitol 1983; 77:131–137.
72. Monlun E, Zeller H, Le Guenno B, et al. Surveillance of the circulation of arbovirus of medical interest in the region of eastern Senegal. Bull Soc Pathol Exot 1993; 86:21–28.
73. Moureau G, Cook S, Lemey P, et al. New insights into flavivirus evolution, taxonomy and biogeographic history, extended by analysis of canonical and alternative coding sequences. PLoS One 2015; 10:e0117849.
74. Peers RR. Bunyamwera virus replication in mosquitoes. Can J Microbiol 1972; 18:741–745.

chikungunya; emergence; transcontinental movement; zika

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.